Hangzhou Xili Intelligent Technology (688616.SH) wins the bid for a national power grid project worth 66.41 million yuan.
Xili Technology (688616.SH) announced that State Grid Corporation recently issued a bid-winning announcement on the State Grid Corporation's e-commerce platform for the "State Grid Corporation Limited 2026 Marketing Project Metering Equipment Special Public Tender Procurement" (Tender No.: 0711-26OTL01122003). The company has been awarded the bid for A-grade single-phase smart meters, B-grade three-phase smart meters, and C-grade three-phase smart meters, with a total bid amount of 66.417 million yuan (including tax). This bid-winning will have a positive impact on the company's operating performance in 2026 and will not affect the company's independence in operation.
Hangzhou Xili Intelligent Technology (688616.SH) announced that State Grid recently issued the bid-winning announcement for the State Grid Corporation 2026 Marketing Project Metering Equipment Special Open Tender Procurement on the State Grid Corporation's e-commerce platform (Tender No.: 0711-26OTL01122003). The company has been awarded the bid for A-level single-phase smart electric energy meters, B-level three-phase smart electric energy meters, and C-level three-phase smart electric meters, with a total bid amount of 66.417 million yuan (including tax). This bid-winning will have a positive impact on the company's operating performance in 2026, and will not affect the company's operational independence.
Related Articles

On March 30, STANCHART (02888) spent 14.95 million British pounds to repurchase 974,400 shares.

"China Resources Gas (01193) spent 81.7938 million Hong Kong dollars to repurchase 433.48 million shares on March 31."

CK Life Sciences (00775) subsidiary SunPur Medicine Technology will present research data on the development of therapeutic cancer vaccines at the AACR 2026 Annual Meeting.
On March 30, STANCHART (02888) spent 14.95 million British pounds to repurchase 974,400 shares.

"China Resources Gas (01193) spent 81.7938 million Hong Kong dollars to repurchase 433.48 million shares on March 31."

CK Life Sciences (00775) subsidiary SunPur Medicine Technology will present research data on the development of therapeutic cancer vaccines at the AACR 2026 Annual Meeting.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


